Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07488351

"Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"

The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Parkinson Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinsonian Disorders Physical Disability Synucleinopathies

Age range

40 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Acibadem University

Istanbul, Turkey, +90, Turkey (Türkiye)

Location status: Recruiting

Location contact

Nuray ALACA

CONTACT

[email protected]

05324251290

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Parkinson's disease
  • Hoehn and Yahr stage 1-3
  • Age 40 to 85 years
  • Mini-Mental State Examination (MMSE) score ≥24
  • Sufficient cognitive function to communicate and complete study assessments
  • Attending the Movement Disorders Outpatient Clinic, Department of Neurology
  • Able and willing to provide written informed consent

Exclusion criteria

  • Major depressive disorder or psychotic disorder
  • Advanced dementia
  • Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension)
  • Severe cardiovascular or respiratory disease
  • Additional neurological or orthopedic conditions that may affect assessment performance
  • Severe visual or hearing impairment that could interfere with study assessments
  • Inability to cooperate with the physiotherapist during study assessments

Treatment and study plan

Self-Report Questionnaire Assessment

Other

This study does not involve any therapeutic intervention. Participants will complete a set of self-report questionnaires assessing self-compassion, self-efficacy, symptom severity, functional status, and quality of life. Data will be collected in a single session for observational analysis.

Primary outcomes

  1. Self-Compassion Scale (SCS) Total Score

    Time frame: Baseline (at the time of questionnaire completion)

    Self-Compassion Scale (SCS) total score. The Self-Compassion Scale consists of 26 items scored on a 1- to 5-point Likert scale. Total scores range from 1 to 5 (calculated as the mean of all items), with higher scores indicating greater self-compassion (better outcome).

  2. Self-Efficacy for Managing Chronic Disease 6-Item Scale Total Score

    Time frame: Baseline (at the time of questionnaire completion)

    Self-Efficacy for Managing Chronic Disease 6-Item Scale total score. The scale consists of 6 items scored from 1 (not at all confident) to 10 (totally confident). The total score is calculated as the mean of the six items, ranging from 1 to 10, with higher scores indicating greater self-efficacy for managing chronic disease (better outcome).

  3. Unified Parkinson's Disease Rating Scale (UPDRS) Total Score

    Time frame: Baseline (at the time of questionnaire completion)

    Unified Parkinson's Disease Rating Scale (UPDRS) total score. The total score ranges from 0 to 199, with higher scores indicating greater Parkinson's disease severity and worse clinical status (worse outcome).

Secondary outcomes

  1. Timed Up and Go (TUG) Test Completion Time in Seconds

    Time frame: Baseline (at the time of questionnaire completion)

    Functional mobility will be measured using the Timed Up and Go (TUG) test. The time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds. Longer times indicate poorer functional mobility.

  2. Six-Minute Walk Test (6MWT) Distance in Meters

    Time frame: Baseline (at the time of questionnaire completion)

    Functional exercise capacity will be measured using the Six-Minute Walk Test (6MWT). The total distance walked in six minutes will be recorded in meters. Greater distances indicate better functional capacity.

  3. Mini-Balance Evaluation Systems Test (Mini-BESTest) Total Score

    Time frame: Baseline (at the time of questionnaire completion)

    Dynamic balance will be measured using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item performance-based assessment. Total scores range from 0 to 28, with higher scores indicating better balance performance.

  4. Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score

    Time frame: Baseline (at the time of questionnaire completion)

    Quality of life will be measured using the Parkinson's Disease Questionnaire-39 (PDQ-39), a validated disease-specific instrument. Total scores range from 0 to 100, with higher scores indicating poorer quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Nuray ALACA

CONTACT

[email protected]

05324251290

Sponsors and collaborators

Lead sponsor

Acibadem University

Other

Registry information

Official study title

"Associations of Self-Compassion and Self-Efficacy With Symptom Severity, Functional Status, and Quality of Life in Individuals With Parkinson's Disease: A Cross-Sectional Study"

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Mar 23, 2026
Registry last updated
Jul 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.